A detailed history of Dearborn Partners LLC transactions in Sanofi stock. As of the latest transaction made, Dearborn Partners LLC holds 5,595 shares of SNY stock, worth $269,007. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,595
Previous 5,548 0.85%
Holding current value
$269,007
Previous $269,000 19.7%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$48.54 - $58.53 $2,281 - $2,750
47 Added 0.85%
5,595 $322,000
Q1 2024

May 08, 2024

BUY
$45.75 - $52.48 $13,038 - $14,956
285 Added 5.42%
5,548 $269,000
Q4 2023

Jan 26, 2024

SELL
$43.13 - $54.79 $50,634 - $64,323
-1,174 Reduced 18.24%
5,263 $261,000
Q3 2023

Nov 01, 2023

BUY
$50.95 - $55.2 $6,368 - $6,900
125 Added 1.98%
6,437 $345,000
Q2 2023

Aug 03, 2023

SELL
$50.45 - $57.18 $7,819 - $8,862
-155 Reduced 2.4%
6,312 $340,000
Q1 2023

May 04, 2023

BUY
$45.86 - $54.45 $6,282 - $7,459
137 Added 2.16%
6,467 $351,000
Q4 2022

Feb 02, 2023

BUY
$38.86 - $48.55 $621 - $776
16 Added 0.25%
6,330 $306,000
Q3 2022

Oct 25, 2022

BUY
$37.22 - $100.5 $235,007 - $634,557
6,314 New
6,314 $240,000
Q1 2022

May 04, 2022

BUY
$48.48 - $53.65 $10,035 - $11,105
207 Added 3.5%
6,115 $314,000
Q4 2021

Jan 28, 2022

BUY
$47.07 - $52.35 $12,614 - $14,029
268 Added 4.75%
5,908 $296,000
Q3 2021

Oct 27, 2021

BUY
$47.89 - $53.12 $957 - $1,062
20 Added 0.36%
5,640 $272,000
Q3 2020

Oct 20, 2020

SELL
$49.47 - $53.77 $8,954 - $9,732
-181 Reduced 3.12%
5,620 $282,000
Q2 2019

Jul 29, 2019

BUY
$40.43 - $44.3 $234,534 - $256,984
5,801 New
5,801 $251,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $121B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.